Ticlopidine
Tohgi, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 570-575
2006
ISSN/ISBN: 0047-1852 PMID: 17461207 Document Number: 598025
Document emailed within 1 workday
Related Documents
Nechifor, M. 1992: Ticlopidine and its use in therapy Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 96(1-2): 39-40Lecompte, T.; Lecrubier, C.; Potevin, F.; Samama, M. 1986: Ticlopidine and platelet function Thrombosis and Haemostasis 55(3): 437-438
Domínguez, J.C.; Nieto, P.; Guerra, F.; Beltrán, C.; Molina, T.; Hidalgo, M.L.; Martín, E.; Martínez, M.C.; Cano, M. 1995: Use of ticlopidine in primary care Atencion Primaria 16(3): 137-140
Villaverde, C.; Cánovas, M.; Padró, T.; Navarro, C. 1984: Ticlopidine as something more than a platelet antiaggregant Archivos de Farmacologia y Toxicologia 10(2): 121-132
Bruguera, M. 1997: Cholestatic hepatitis associated with ticlopidine Gastroenterologia y Hepatologia 20(3): 163-164
Brigot, C.; Courillon-Mallet, A.; Roucayrol, A.M.; Cattan, D. 1998: Lymphocytic colitis and ticlopidine Gastroenterologie Clinique et Biologique 22(3): 361-362
Marmont, A.M.; Lotti, G.; Nati, S.; Martinengo, M.; Morgano, A. 1985: Agranulocytosis caused by ticlopidine Recenti Progressi in Medicina 76(5): 245-248
McCullough, P.A.; Marks, K.R. 1999: Ticlopidine and TTP after coronary stenting JAMA 282(18): 1717-8; author reply 1718-9
Chen, L.K.; Hsieh, B.H.; Chen, W.C.; Tsai, S.T.; Hou, M.C. 2001: Ticlopidine-induced hepatitis Zhonghua Yi Xue Za Zhi 64(1): 59-63
Caliendo, G.; Bradbury, K.; Mehl, B. 1994: Ticlopidine, bleeding, and surgery Mount Sinai Journal of Medicine new York 61(4): 372-373
Yoder, J.D.; Algozzine, G.J.; Hill, G.W. 1994: More ticlopidine-induced cholestatic jaundice American Journal of Hospital Pharmacy 51(14): 1821-1822
Panak, E.; Blanchard, J.; Roe, R.L. 1984: Evaluation of the antithrombotic efficacy of ticlopidine in man Agents and Actions. Supplements 15: 148-166
Lesesve, J.F.; Noblet, C.; Stamatoullas, A.; Gueit, I.; Moore, N.; Monconduit, M. 1995: Adverse hematologic effects of ticlopidine Therapie 50(5): 468-470
Porter, T.; Leibovittz, E.; Berliner, S. 1995: Ticlopidine in coronary artery diseases Harefuah 129(10): 427-430
Sánchez Ayuso, J.; Fernández González, F.; Fernández Rodríguez, E. 1997: Ticlopidine and bone marrow aplasia Medicina Clinica 109(16): 649
Varvello, L.; Arnò, C.; Coggiola, M.; Ramassotto, E.; Pascale, C. 2002: Cholestasis from ticlopidine: two clinical cases Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 17(4): 252-255
Day, H.J. 1984: Overview: clinical experiences with ticlopidine Agents and Actions. Supplements 15: 297-309
Spiera, R.F.; Berman, R.S.; Werner, A.J.; Spiera, H. 2002: Ticlopidine-induced lupus: a report of 4 cases Archives of Internal Medicine 162(19): 2240-2243
Hsu, V.D. 1993: Criteria for use of ticlopidine in adult inpatients and outpatients Clinical Pharmacy 12(1): 64-66
Remy, A.J.; Heran, B.; Galindo, G.; Tapie, C.; Khemissa, F.; Larrey, D. 1999: A new drug responsible for microvesicular steatosis: ticlopidine Gastroenterologie Clinique et Biologique 23(1): 151-152